4//SEC Filing
GRAYZEL DAVID S. 4
Accession 0000950170-24-096989
CIK 0001661998other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:05 PM ET
Size
6.1 KB
Accession
0000950170-24-096989
Insider Transaction Report
Form 4
Q32 Bio Inc.QTTB
GRAYZEL DAVID S.
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-04-01$13.42/sh+2,569$34,476→ 2,569 totalExercise: $18.00Exp: 2034-03-31→ Common Stock (2,569 underlying)
Footnotes (3)
- [F1]This option was granted in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive equity in lieu of cash compensation for services as a non-employee director of the Issuer.
- [F2]The shares underlying this option shall vest in three equal quarterly installments on each of June 30, 2024, September 30, 2024 and December 31, 2024.
- [F3]This option was granted to the Reporting Person, a director of the Issuer. The proceeds of any sale of shares of common stock issued to the Reporting Person upon exercise of this option will be transferred to Atlas Venture Life Science Advisors, LLC and as such, the Reporting Person disclaims ownership of such securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Q32 Bio Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001732786
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:05 PM ET
- Size
- 6.1 KB